2024 Annual Impact Report

2024 was a catalyst for even broader impact. From expanding patient engagement to creating new tools for data-sharing and collaboration, we are laying the groundwork for a future where rare cancer research is faster and more streamlined.

Next
Next

2023 Annual Impact Report